Trials / Completed
CompletedNCT05634551
Perceptions on Expected Outcomes of Immunotherapy in Advanced Cancer Patients With Poor Performance Status
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 15 (actual)
- Sponsor
- M.D. Anderson Cancer Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To better understand your feelings and expectations about immunotherapy
Detailed description
Primary Objective: 1\. To compare expectations of survival benefit from immunotherapy between advanced cancer patients with poor performance status (PS) and their oncologists. We hypothesize that, compared to their oncologists, patients will have expectations for greater likelihood of survival beyond 2 years. Secondary Objectives: 1. To compare expectations of therapeutic benefit of immunotherapy between advanced cancer patients with poor PS and their oncologists. We hypothesize that, compared to their oncologists, patients will have expectations for greater likelihood of cure, quality of life improvement, and lower likelihood of adverse events. 2. To qualitatively describe the priorities and preferences for information of advanced cancer patients with poor PS when considering immunotherapy treatment. 3. To evaluate the associations between discrepant expectations with patients' sociodemographic and clinical characteristics. 4. To compare patient and oncologist expectations with actual treatment outcomes and survival.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Questionnaires | Participants will complete 5 questionnaires about any symptoms participants may be having, any anxiety and/or depression participants may be having, your preference in decision-making, and your expectations about your treatment. It should take about 30 minutes to complete all 5 questionnaires |
| BEHAVIORAL | Interview | The interview will last about 30-45 minutes. The interview will be conducted over the phone or remotely over Zoom or FaceTime (based on your preference) |
Timeline
- Start date
- 2023-02-09
- Primary completion
- 2024-08-02
- Completion
- 2024-08-02
- First posted
- 2022-12-02
- Last updated
- 2024-08-06
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05634551. Inclusion in this directory is not an endorsement.